Preswitch Regimens Associated With Weight Gain Among Persons With HIV who Switch to Integrase Inhibitor-Containing Regimens. [PDF]
Cutshaw MK+3 more
europepmc +1 more source
Integrase Inhibitor Resistance Mechanisms and Structural Characteristics in Antiretroviral Therapy-Experienced, Integrase Inhibitor-Naive Adults with HIV-1 Infection Treated with Dolutegravir plus Two Nucleoside Reverse Transcriptase Inhibitors in the DAWNING Study. [PDF]
Underwood M+9 more
europepmc +1 more source
Exploring Zinc C295 as a Dual HIV-1 Integrase Inhibitor: From Strand Transfer to 3'-Processing Suppression. [PDF]
Sayyed SK+8 more
europepmc +1 more source
An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor-based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1. [PDF]
Evitt LA+5 more
europepmc +1 more source
Human Immunodeficiency Virus Integrase Pharmacophore Model Derived from Diketoacids Inhibitors [PDF]
Xiaoyi Zhang
openalex +1 more source
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment. [PDF]
Pyngottu A+14 more
europepmc +1 more source
DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. [PDF]
Anderson D+8 more
europepmc +1 more source
Integrase inhibitors in the treatment of HIV-1 infection [PDF]
William G. Powderly
openalex +1 more source
HIV-1 Genetic Diversity and Natural Polymorphisms of the Integrase Gene in Integrase Inhibitor-Naive Patients in Harare, Zimbabwe. [PDF]
Madyadi A+7 more
europepmc +1 more source